Trial Profile
Anti-B- Cell Treatment and Tnf-Inhibitors in Rheumatoid Arthritis Patients-Real-World Data from the Russian North-Western Biological Treatment Cohort
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 15 Jul 2018 New trial record
- 16 Jun 2018 Results assessing efficacy and safety of biological treatment, presented at the 19th Annual Congress of the European League Against Rheumatism